M&A / Deals Aditxt and Ignite announce merger plans with strategic partner Pharmaceutical TechnologyAditxt and subsidiary Ignite Proteomics have announced plans for a business combination with a strategic partner.Read full story pharminent June 10, 2026 (Last updated: June 10, 2026) Pharmaceutical Technology Aditxt and subsidiary Ignite Proteomics have announced plans for a business combination with a strategic partner. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Cancer biotech Parabilis books record IPO, raising $670mNext: AbbVie’s migraine drug cleared for migraine attacks on NHS Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
